Corlanor (ivabradine) tablets recall — Class II (D-0612-2026) · pharmaranks
Class IIOngoing
Corlanor (ivabradine) tablets recall
FDA recall D-0612-2026 · initiated Jun 4, 2026
By the pharmaranks editorial team·Reviewed against the FDA (openFDA) sources·Updated Jul 1, 2026·How we research
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Presence of Foreign Substance.
Details
Product
Corlanor (ivabradine) tablets, 5 mg, packaged in a) 14 tablets bottles (NDC 55513-800-99), and b) 60 tablet bottles (NDC 55513-800-60), Rx Only, Amgen Inc., Thousand Oaks, CA 92130 Made In Italy.
This recall is linked to a product we cover: Corlanor →
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.